Search

Search Constraints

You searched for: Subject 616.995

Search Results

1341. Validity of a CB-NAAT assay in diagnosing tuberculosis in comparison to culture: A study from an urban area of South India. (December 2020)

1342. Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages stimulated with IFN-γ. (January 2019)

1343. Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails. (May 2017)

1344. Variances in BCG protection against COVID-19 mortality: A global assessment. (August 2021)

1345. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. (December 2017)

1346. Variation in tuberculosis treatment outcomes and treatment supervision practices in Uganda. (December 2020)

1347. Vascular endothelial growth factor (VEGF) and interleukin-1 receptor antagonist (IL-1Ra) as promising biomarkers for distinguishing active from latent tuberculosis in children and adolescents. (May 2022)

1348. Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature. (May 2023)

1349. Verification of tuberculosis infection among Vác mummies (18th century CE, Hungary) based on lipid biomarker profiling with a new HPLC-HESI-MS approach. (January 2021)